Medilync
Cloud-based platform that allows for easier disease self-management for diabetic patients.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
€50.0k | Grant | ||
| Total Funding | 000k | ||
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (17 %) | 3 % | (50 %) | - | - | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 20 % | 36 % | (8 %) | - | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 2 % | 14 % | (56 %) | - | - | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Medilync is a forward-thinking startup focused on revolutionizing diabetes management. The company aims to simplify disease self-management for diabetic patients and enhance communication between patients, their families, and healthcare providers. Medilync operates in the healthcare technology market, specifically targeting diabetes care.
The company's flagship product, Insulync, utilizes computer vision technology to accurately log insulin doses administered with analog pens. This technology is also applicable to glucometers, ensuring precise tracking of glucose levels. Insulync automatically syncs data to Cloudlync, Medilync's cloud-based platform, providing real-time information accessible to patients, families, and doctors. This seamless data integration helps in better disease management and informed decision-making.
Medilync's business model revolves around offering these innovative tools and platforms to healthcare providers, patients, and their families. By creating a network that facilitates effective communication and real-time data sharing, Medilync enhances the overall management of diabetes. The company generates revenue through the sale of its products and services, including subscriptions to its cloud platform and potential partnerships with healthcare institutions.
Medilync's team comprises IT innovators, behavioral specialists, and healthcare experts, all dedicated to improving population health management. Their solutions address some of the most costly problems in healthcare by engaging patients and stakeholders and building predictive health analytics tools. The open cloud platform allows for integration with various devices and electronic medical records (EMRs), providing healthcare providers with a comprehensive understanding of patient data.
In summary, Medilync is transforming diabetes management through innovative technology, real-time data integration, and effective communication networks, ultimately improving patient outcomes and reducing healthcare costs.
Keywords: Diabetes, Management, Insulync, Cloudlync, Healthcare, Technology, Real-time Data, Communication, Population Health, Analytics.